HomeAPLS • NASDAQ
add
Apellis Pharmaceuticals Inc
Previous close
$21.42
Day range
$20.82 - $21.89
Year range
$16.10 - $30.48
Market cap
2.80B USD
Avg Volume
3.15M
P/E ratio
122.89
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 199.91M | -5.94% |
Operating expense | 442.96M | 264.63% |
Net income | -58.95M | -62.16% |
Net profit margin | -29.49 | -72.36% |
Earnings per share | -0.47 | -62.07% |
EBITDA | -50.82M | -97.59% |
Effective tax rate | -0.53% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 466.23M | 12.04% |
Total assets | 1.08B | 21.49% |
Total liabilities | 705.11M | 7.40% |
Total equity | 370.15M | — |
Shares outstanding | 127.83M | — |
Price to book | 7.34 | — |
Return on assets | -11.98% | — |
Return on capital | -14.86% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -58.95M | -62.16% |
Cash from operations | -14.18M | -173.22% |
Cash from investing | -108.00K | -440.00% |
Cash from financing | 1.26M | 131.48% |
Net change in cash | -12.84M | -189.33% |
Free cash flow | -114.87M | -307.16% |
About
Founded
2009
Headquarters
Website
Employees
733
